Dr. Amirul I. Mallick
Affiliation (Present and Past)
Current Position: Professor, Dept. of Biological Sciences (2025-to date)
Ph.D (Biotechnology): Research area: Molecular Immunology, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India (2003-2008)
MVSc/DVM (Microbiology and Immunology): CSA University of Agriculture and Technology, Kanpur, UP, India (2001-2003)
BVSc and AH (Veterinary Medicine): West Bengal University of Animal and Fishery Sciences, Kolkata, India (1996-2001)
Post doctoral research: Molecular Targeting and Biotherapeutics Lab, Sunnybrook Research Institute, University of Toronto, Canada (2010-2014).
Post doctoral research: Pathobiology, Ontario Veterinary Collge, University of Guelph, Canada (2008-2010).
Awards and Honors
Recipent of Scientific High Level Visiting Fellowships (SSHN)2024 by the Indian French Institute: for short term research visit to University of Saint-Etienne, October 2024.
The Royal Society-BactiVac UK Travel Bursary award : to attend the "Vaccines and antimicrobial resistance: from science to policy" meeting in London, 29-30 April 2024.
Recipient of "BactiVac Catalyst Pump Priming Grant-2023": from the Bacterial Vaccine Network, University of Birmingham, UK.
Recipient of "21st International Vaccine Institute (IVI) (Seoul, S. Korea): Course Fellow" award 2022:
ICMR-DHR International Fellowship:(2020 and 2022):
National Nomminee-:Committee for Control And Supervision of Experiments on Animals (CCSEA) (Govt. of India)(2018-):
SERB Early Career Research Award :(2016):
Canadian Breast Cancer Foundation Fellowship (CBCF):(2012):
International Travel Award :from ICI and Canadian Society for Immunology(CSI)(2010):
Senior Research Fellowship :from Council of Scientific and Ind. Res.(CSIR), New Delhi (2006):
Post Graduate merit scholarship :from CSA University of Agrl. and Technol, Kapnur (2001):
Funded Projects (Completed/ongoing)
(Ongoing) Understanding the role of the Type II MLA system in OMV biogenesis: towards developing an effective vaccine against Campylobacter jejuni in poultry(Indo-UK joint funding by DBT, Govt. of India and BBSRC, UKRI, 2024-2027
(Ongoing) Live vector-based multivalent vaccine against cecal colonisation of Campylobacter jejuni in commercial chickens, (BactiVac Network, University of Birmingham, UK), 2023-2024
(Ongoing) Multimodal Photocatalytic Therapy Based on NIR-Active Perovskite-Peptide Nanocomposites for Hard-To-Treat Lung Biofilm Infection. (MoE-STARS, Govt of India) 2023-2026
(Ongoing) Bioengineering Bacterial Extracellular Vesicles (BEVs) as a multifunctional oral delivery platform for biomedical applications. (SERB-CRG, Govt of India) (2023-2026)
(Ongoing) Developing a multi-compartment mathematical model for understanding the immune-senescence in adults. (SERB TARE Program)(2023-2026)
(Ongoing) Assessing the immuno-therapeutic potential of type III interferons-IFNs (IFN-lambda) against Type A Influenza virus infections in chicken and murine model. (Dept. of Biotechnology (2021-2024)
(Ongoing) Campylobacter jejuni Outer Membrane Vesicles: Role in Host-Pathogen Interaction and vaccine perspectives in chicken and murine model. (Dept. of Biotechnology (2021-2024)
(Completed) Assessing anti-viral potential of nano-particle treated Plywood and Laminated products. (Century Plyboard (I) Ltd, Kolkata) (2021-2024)
(Ongoing) Reproductive Toxicity Study of a test compound by splenic lymphocyte sub-population analysis (Krish Biotech, Kalyani, India)(2022-2023)
(Completed) Anti-viral efficacy of a paper-based biocidal disinfectant coating.(Indian Tobacco Corporation Ltd (ITC) India)(2020-2021):
(Completed) Studying the mechanism of host adaptation by Campylobacter jejuni and developing strategies to control enteric commensalism in chicken. (Dept. of Biotechnology, Govt. of India) (2018-21)
(Completed) Strategy for developing a safe and effective control measure against Avian Influenza in chicken: live vector-based mucosal vaccine approach. (DST SERB, Govt. of India)(2016-2019)